Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia

    HLA, Vol. 99, Núm. 2, pp. 93-104

2017

  1. Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma

    OncoTargets and Therapy, Vol. 10, pp. 503-514

2012

  1. Ctl responses of high functional avidity and broad variant cross-reactivity are associated with hiv control

    PLoS ONE, Vol. 7, Núm. 1